Li Y - Search Results

1

MiR-92b targets p57kip2 to modulate the resistance of hepatocellular carcinoma (HCC) to ionizing radiation (IR) -based radiotherapy.

Wang J, Zhao H, Yu J, Xu X, Liu W, Jing H, Li N, Tang Y, Li Y, Cai J, Jin J. Wang J, et al. Among authors: li y, li n. Biomed Pharmacother. 2019 Feb;110:646-655. doi: 10.1016/j.biopha.2018.11.080. Epub 2018 Dec 10. Biomed Pharmacother. 2019. PMID: 30544064 Free article.

2

A phase I study of concurrent radiotherapy and capecitabine as adjuvant treatment for operable rectal cancer.

Jin J, Li YX, Liu YP, Wang WH, Song YW, Li T, Li N, Yu ZH, Liu XF. Jin J, et al. Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):725-9. doi: 10.1016/j.ijrobp.2005.08.017. Epub 2005 Oct 19. Int J Radiat Oncol Biol Phys. 2006. PMID: 16242260 Clinical Trial.

3

Primary early-stage intestinal and colonic non-Hodgkin's lymphoma: clinical features, management, and outcome of 37 patients.

Wang SL, Liao ZX, Liu XF, Yu ZH, Gu DZ, Qian TN, Song YW, Jin J, Wang WH, Li YX. Wang SL, et al. World J Gastroenterol. 2005 Oct 7;11(37):5905-9. doi: 10.3748/wjg.v11.i37.5905. World J Gastroenterol. 2005. PMID: 16270408 Free PMC article.

4

Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma.

Li YX, Yao B, Jin J, Wang WH, Liu YP, Song YW, Wang SL, Liu XF, Zhou LQ, He XH, Lu N, Yu ZH. Li YX, et al. J Clin Oncol. 2006 Jan 1;24(1):181-9. doi: 10.1200/JCO.2005.03.2573. J Clin Oncol. 2006. PMID: 16382127

5

[Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].

Yao B, Li YX, Fang H, Jin J, Liu XF, Yu ZH. Yao B, et al. Ai Zheng. 2006 Apr;25(4):465-70. Ai Zheng. 2006. PMID: 16613682 Chinese.

6

[Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].

Yao B, Li YX, Song YW, Jin J, Liu YP, Wang WH, Wang SL, Sun YT, Yu ZH, Liu XF. Yao B, et al. Zhonghua Zhong Liu Za Zhi. 2006 Jan;28(1):58-61. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 16737624 Chinese.

7

[Prognostic factors and treatment outcome in early stage nasal NK/T cell lymphoma].

Yao B, Li YX, Fang H, Yu ZH, Jin J, Liu XF. Yao B, et al. Zhonghua Xue Ye Xue Za Zhi. 2006 Apr;27(4):222-5. Zhonghua Xue Ye Xue Za Zhi. 2006. PMID: 16875550 Chinese.

8

[Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease].

Wang WH, Li YX, Song YW, Jin J, Liu YP, Wang SL, Zhou LQ, Liu XF, Yu ZH, Han JZ. Wang WH, et al. Zhonghua Zhong Liu Za Zhi. 2006 Mar;28(3):218-21. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 16875611 Chinese.

9

[Phase I study of postoperative concurrent chemoradiation with capecitabine as adjuvant treatment for stage II/III operable rectal cancer].

Jin J, Li YX, Liu YP, Wang WH, Li T, Li N, Song YW. Jin J, et al. Zhonghua Zhong Liu Za Zhi. 2006 May;28(5):393-6. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17045010 Clinical Trial. Chinese.

10

[Expression profile of nasal NK/T cell lymphoma by cDNA microarray].

Wang WH, Li YX, Lin C, Liu XF, Yu ZH, Song YW, Zhang XY, Fu M, Jin J, Wang SL, Liu YP. Wang WH, et al. Zhonghua Zhong Liu Za Zhi. 2006 Jul;28(7):518-22. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17147117 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235,560 results

Search Page

Filters